Hydrochlorothiazide and risk of melanoma subtypes.
Laurel A HabelNinah AchacosoBruce FiremanSidsel Arnspang PedersenJesper HallasPublished in: Pharmacoepidemiology and drug safety (2021)
Our findings support a recent report of an association between high use of HCTZ and increased risk of the lentigo subtype of melanoma.
Keyphrases